The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Effect of toxicity-adjusted dose (TAD) of sunitinib on intra-patient variation of trough levels: A longitudinal study in metastatic renal cell cancer (mRCC).
Alison Yan Zhang
No relevant relationships to disclose
Peter Fox
No relevant relationships to disclose
Sally Coulter
No relevant relationships to disclose
Bavanthi Balakrishnar
No relevant relationships to disclose
Christopher Liddle
No relevant relationships to disclose
Howard Gurney
No relevant relationships to disclose